← All companies

CRDL

Cardiol Therapeutics Inc.

CRDL Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.31

+0.04 +3.15%

Key statistics

from XBRL data in SEC filings

Market cap

$131M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.88 – $1.71

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 14, 2026 6-K FORM 6-K Jul 9, 2026 6-K FORM 6-K Jun 25, 2026 6-K FORM 6-K Jun 23, 2026 6-K FORM 6-K May 26, 2026 6-K FORM 6-K May 14, 2026 6-K FORM 6-K May 11, 2026 6-K FORM 6-K May 7, 2026 6-K FORM 6-K Apr 28, 2026 6-K FORM 6-K Apr 14, 2026 6-K FORM 6-K Apr 10, 2026 6-K FORM 6-K Apr 1, 2026 40-F Mar 31, 2026 6-K FORM 6-K Feb 25, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Feb 2, 2026 6-K FORM 6-K Jan 26, 2026 6-K FORM 6-K Jan 23, 2026 6-K FORM 6-K Jan 16, 2026 6-K FORM 6-K Jan 13, 2026 6-K FORM 6-K Dec 1, 2025 6-K FORM 6-K Nov 13, 2025 6-K FORM 6-K Nov 13, 2025 6-K FORM 6-K Nov 5, 2025 6-K FORM 6-K Oct 28, 2025 6-K FORM 6-K Oct 27, 2025 6-K FORM 6-K Oct 21, 2025 6-K FORM 6-K Oct 17, 2025 6-K FORM 6-K Aug 14, 2025 6-K FORM 6-K Aug 11, 2025 6-K FORM 6-K Aug 6, 2025 6-K FORM 6-K Jul 22, 2025 6-K FORM 6-K May 29, 2025 6-K FORM 6-K May 27, 2025 6-K FORM 6-K May 14, 2025 6-K FORM 6-K Apr 29, 2025 6-K FORM 6-K Apr 28, 2025 6-K FORM 6-K Apr 16, 2025 6-K FORM 6-K Apr 1, 2025 40-F Mar 31, 2025